Skip to main content
Erschienen in: Diabetologia 1/2003

01.01.2003 | Article

Proinsulin and acute insulin response independently predict Type 2 diabetes mellitus in men—report from 27 years of follow-up study

verfasst von: B. Zethelius, MD, L. Byberg, C. N. Hales, H. Lithell, C. Berne

Erschienen in: Diabetologia | Ausgabe 1/2003

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Defects in insulin secretion and insulin action, resulting in compensatory hyperinsulinaemia, are the major abnormalities in the development of Type 2 diabetes mellitus (Type 2 diabetes). The most frequently used conventional immunoreactive assays for insulin cross-react with proinsulin. In short-term studies (<5 years), proinsulin predicts the development of Type 2 diabetes. We studied, with a 27-year follow-up, the longitudinal relationships between intact proinsulin, 32–33 split proinsulin, specific and immunoreactive insulin (IRI), acute insulin response (AIR) after an intravenous glucose load and the development of Type 2 diabetes in a population-based cohort of 50-year-old men.

Methods

Fasting peptide concentrations were measured in plasma samples, stored since 1970–73 using specific two-site immunometric assays. IRI was measured at baseline using radioimmunoassay. Associations between development of Type 2 diabetes and predictor variables, were analysed with logistic regression. Results are shown as odds ratios (ORs) with their 95% confidence intervals (CIs) for a one standard deviation increase in a predictor variable.

Results

Cumulative incidence of Type 2 diabetes was 33% over 27 years of follow-up. Intact proinsulin (OR, 1.57, CI, 1.16–2.14), and 32–33 split proinsulin (OR, 1.70, CI, 1.20–2.39) were associated with development of Type 2 diabetes, independent of AIR, adjusted for BMI and fasting glucose, whereas specific insulin was not (OR, 1.31, CI, 0.98–1.77), nor was IRI (OR, 1.25, CI, 0.96–1.63). Proinsulin and AIR interacted in the development of Type 2 diabetes (p<0.05).

Conclusion/interpretation

Proinsulin predicts the development of Type 2 diabetes mellitus over a 27-year period.
Literatur
1.
Zurück zum Zitat Gerich JE (1998) The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocr Rev 19:491–503PubMed Gerich JE (1998) The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocr Rev 19:491–503PubMed
2.
Zurück zum Zitat Lillioja S, Mott DM, Spraul M et al. (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329:1988–1992PubMed Lillioja S, Mott DM, Spraul M et al. (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329:1988–1992PubMed
3.
Zurück zum Zitat Weyer C, Tataranni PA, Bogardus C, Pratley RE (2001) Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care 24:89–94PubMed Weyer C, Tataranni PA, Bogardus C, Pratley RE (2001) Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care 24:89–94PubMed
4.
Zurück zum Zitat Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH (1988) The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med 319:1500–1506PubMed Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH (1988) The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med 319:1500–1506PubMed
5.
Zurück zum Zitat Haffner SM, Miettinen H, Gaskill SP, Stern MP (1995) Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes 44:1386–1391PubMed Haffner SM, Miettinen H, Gaskill SP, Stern MP (1995) Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes 44:1386–1391PubMed
6.
Zurück zum Zitat Skarfors ET, Selinus KI, Lithell HO (1991) Risk factors for developing non-insulin dependent diabetes: a 10 year follow up of men in Uppsala. BMJ 303:755–760PubMed Skarfors ET, Selinus KI, Lithell HO (1991) Risk factors for developing non-insulin dependent diabetes: a 10 year follow up of men in Uppsala. BMJ 303:755–760PubMed
7.
Zurück zum Zitat Charles MA, Fontbonne A, Thibult N, Warnet JM, Rosselin GE, Eschwege E (1991) Risk factors for NIDDM in white population. Paris prospective study. Diabetes 40:796–799PubMed Charles MA, Fontbonne A, Thibult N, Warnet JM, Rosselin GE, Eschwege E (1991) Risk factors for NIDDM in white population. Paris prospective study. Diabetes 40:796–799PubMed
8.
Zurück zum Zitat Mykkanen L, Kuusisto J, Pyorala K, Laakso M (1993) Cardiovascular disease risk factors as predictors of type II (non- insulin-dependent) diabetes mellitus in elderly subjects. Diabetologia 36:553–559PubMed Mykkanen L, Kuusisto J, Pyorala K, Laakso M (1993) Cardiovascular disease risk factors as predictors of type II (non- insulin-dependent) diabetes mellitus in elderly subjects. Diabetologia 36:553–559PubMed
9.
Zurück zum Zitat Saad MF, Anderson RL, Laws A et al. (1994) A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study. Diabetes 43:1114–1121PubMed Saad MF, Anderson RL, Laws A et al. (1994) A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study. Diabetes 43:1114–1121PubMed
10.
Zurück zum Zitat Laakso M (1993) How good a marker is insulin level for insulin resistance? Am J Epidemiol 137:959–965PubMed Laakso M (1993) How good a marker is insulin level for insulin resistance? Am J Epidemiol 137:959–965PubMed
11.
Zurück zum Zitat Hanley AJ, D'Agostino R Jr, Wagenknecht et al. (2002) Increased proinsulin levels and decreased acute insulin response independently predict the incidence of type 2 diabetes in the insulin resistance atherosclerosis study. Diabetes 51:1263–1270PubMed Hanley AJ, D'Agostino R Jr, Wagenknecht et al. (2002) Increased proinsulin levels and decreased acute insulin response independently predict the incidence of type 2 diabetes in the insulin resistance atherosclerosis study. Diabetes 51:1263–1270PubMed
12.
Zurück zum Zitat Wareham NJ, Byrne CD, Williams R, Day NE, Hales CN (1999) Fasting proinsulin concentrations predict the development of type 2 diabetes. Diabetes Care 22:262–270PubMed Wareham NJ, Byrne CD, Williams R, Day NE, Hales CN (1999) Fasting proinsulin concentrations predict the development of type 2 diabetes. Diabetes Care 22:262–270PubMed
13.
Zurück zum Zitat Haffner SM, Gonzalez C, Mykkanen L, Stern M (1997) Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes Study. Diabetologia 40:830–837CrossRefPubMed Haffner SM, Gonzalez C, Mykkanen L, Stern M (1997) Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes Study. Diabetologia 40:830–837CrossRefPubMed
14.
Zurück zum Zitat Nijpels G, Popp-Snijders C, Kostense PJ, Bouter LM, Heine RJ (1996) Fasting proinsulin and 2-h post-load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: the Hoorn Study. Diabetologia 39:113–118PubMed Nijpels G, Popp-Snijders C, Kostense PJ, Bouter LM, Heine RJ (1996) Fasting proinsulin and 2-h post-load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: the Hoorn Study. Diabetologia 39:113–118PubMed
15.
Zurück zum Zitat Kahn SE, Leonetti DL, Prigeon RL, Boyko EJ, Bergstrom RW, Fujimoto WY (1995) Proinsulin as a marker for the development of NIDDM in Japanese-American men. Diabetes 44:173–179PubMed Kahn SE, Leonetti DL, Prigeon RL, Boyko EJ, Bergstrom RW, Fujimoto WY (1995) Proinsulin as a marker for the development of NIDDM in Japanese-American men. Diabetes 44:173–179PubMed
16.
Zurück zum Zitat Mykkanen L, Haffner SM, Kuusisto J, Pyorala K, Hales CN, Laakso M (1995) Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects. Diabetologia 38:1176–82CrossRefPubMed Mykkanen L, Haffner SM, Kuusisto J, Pyorala K, Hales CN, Laakso M (1995) Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects. Diabetologia 38:1176–82CrossRefPubMed
17.
Zurück zum Zitat Mykkanen L, Haffner SM, Hales CN, Ronnemaa T, Laakso M (1997) The relation of proinsulin, insulin, and proinsulin-to-insulin ratio to insulin sensitivity and acute insulin response in normoglycemic subjects. Diabetes 46:1990–1995PubMed Mykkanen L, Haffner SM, Hales CN, Ronnemaa T, Laakso M (1997) The relation of proinsulin, insulin, and proinsulin-to-insulin ratio to insulin sensitivity and acute insulin response in normoglycemic subjects. Diabetes 46:1990–1995PubMed
18.
Zurück zum Zitat Mykkanen L, Zaccaro DJ, Hales CN, Festa A, Haffner SM (1999) The relation of proinsulin and insulin to insulin sensitivity and acute insulin response in subjects with newly diagnosed Type II diabetes: the Insulin Resistance Atherosclerosis Study. Diabetologia 42:1060–1066CrossRefPubMed Mykkanen L, Zaccaro DJ, Hales CN, Festa A, Haffner SM (1999) The relation of proinsulin and insulin to insulin sensitivity and acute insulin response in subjects with newly diagnosed Type II diabetes: the Insulin Resistance Atherosclerosis Study. Diabetologia 42:1060–1066CrossRefPubMed
19.
Zurück zum Zitat Hedstrand H (1975) A study of middle-aged men with particular reference to risk factors for cardiovascular disease. Ups J Med Sci 80 [Suppl 19]:1–61 Hedstrand H (1975) A study of middle-aged men with particular reference to risk factors for cardiovascular disease. Ups J Med Sci 80 [Suppl 19]:1–61
20.
Zurück zum Zitat Zethelius B, Byberg L, Hales CN, Lithell H, Berne C (2002) Proinsulin is an independent predictor of coronary heart disease: report from a 27-year follow-up study. Circulation 105:2153–2158CrossRefPubMed Zethelius B, Byberg L, Hales CN, Lithell H, Berne C (2002) Proinsulin is an independent predictor of coronary heart disease: report from a 27-year follow-up study. Circulation 105:2153–2158CrossRefPubMed
21.
Zurück zum Zitat Skarfors ET, Lithell HO, Selinus I (1991) Risk factors for the development of hypertension: a 10-year longitudinal study in middle-aged men. J Hypertens 9:217–223PubMed Skarfors ET, Lithell HO, Selinus I (1991) Risk factors for the development of hypertension: a 10-year longitudinal study in middle-aged men. J Hypertens 9:217–223PubMed
22.
Zurück zum Zitat Lithell H, Sundstrom J, Arnlov J et al. (2000) Epidemiological and clinical studies on insulin resistance and diabetes. Ups J Med Sci 105:135–150PubMed Lithell H, Sundstrom J, Arnlov J et al. (2000) Epidemiological and clinical studies on insulin resistance and diabetes. Ups J Med Sci 105:135–150PubMed
23.
Zurück zum Zitat World Health Organisation (1999) Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. WHO/NCD/NCS/99.2 World Health Organization, Geneva World Health Organisation (1999) Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. WHO/NCD/NCS/99.2 World Health Organization, Geneva
24.
Zurück zum Zitat Sobey WJ, Beer SF, Carrington CA, Clark PMS, Hales CN (1989) Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65–66 split and 32–33 split proinsulins. Biochem J 260:535–541PubMed Sobey WJ, Beer SF, Carrington CA, Clark PMS, Hales CN (1989) Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65–66 split and 32–33 split proinsulins. Biochem J 260:535–541PubMed
25.
Zurück zum Zitat Rhodes CJ, Alarcon C (1994) What beta-cell defect could lead to hyperproinsulinemia in NIDDM? Some clues from recent advances made in understanding the proinsulin-processing mechanism. Diabetes 43:511–517PubMed Rhodes CJ, Alarcon C (1994) What beta-cell defect could lead to hyperproinsulinemia in NIDDM? Some clues from recent advances made in understanding the proinsulin-processing mechanism. Diabetes 43:511–517PubMed
26.
Zurück zum Zitat Yoshioka N, Kuzuya T, Matsuda A, Taniguchi M, Iwamoto Y (1988) Serum proinsulin levels at fasting and after oral glucose load in patients with Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 31:355–360PubMed Yoshioka N, Kuzuya T, Matsuda A, Taniguchi M, Iwamoto Y (1988) Serum proinsulin levels at fasting and after oral glucose load in patients with Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 31:355–360PubMed
27.
Zurück zum Zitat Roder ME, Porte D Jr, Schwartz RS, Kahn SE (1998) Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 83:604–608PubMed Roder ME, Porte D Jr, Schwartz RS, Kahn SE (1998) Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 83:604–608PubMed
28.
Zurück zum Zitat Allison DB, Paultre F, Goran MI, Poehlman ET, Heymsfield SB (1995) Statistical considerations regarding the use of ratios to adjust data. Int J Obes Relat Metab Disord 19:644–652PubMed Allison DB, Paultre F, Goran MI, Poehlman ET, Heymsfield SB (1995) Statistical considerations regarding the use of ratios to adjust data. Int J Obes Relat Metab Disord 19:644–652PubMed
29.
Zurück zum Zitat Roder ME, Dinesen B, Hartling et al. (1999) Intact proinsulin and beta-cell function in lean and obese subjects with and without type 2 diabetes. Diabetes Care 22:609–614PubMed Roder ME, Dinesen B, Hartling et al. (1999) Intact proinsulin and beta-cell function in lean and obese subjects with and without type 2 diabetes. Diabetes Care 22:609–614PubMed
30.
Zurück zum Zitat Lang DA, Matthews DR, Peto J, Turner RC (1979) Cyclic oscillations of basal plasma glucose and insulin concentrations in human beings. N Engl J Med 301:1023–1027PubMed Lang DA, Matthews DR, Peto J, Turner RC (1979) Cyclic oscillations of basal plasma glucose and insulin concentrations in human beings. N Engl J Med 301:1023–1027PubMed
31.
Zurück zum Zitat World Health Organisation (1980) WHO Expert Committee on Diabetes Mellitus: second report. Technical Report Series No 646 World Health Organisation, Geneva World Health Organisation (1980) WHO Expert Committee on Diabetes Mellitus: second report. Technical Report Series No 646 World Health Organisation, Geneva
32.
Zurück zum Zitat (No authors listed) (1998) Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group. BMJ 317:371–375PubMed (No authors listed) (1998) Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group. BMJ 317:371–375PubMed
33.
Zurück zum Zitat Khaw KT, Wareham N, Luben R et al. (2001) Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ 322:15–18CrossRefPubMed Khaw KT, Wareham N, Luben R et al. (2001) Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ 322:15–18CrossRefPubMed
Metadaten
Titel
Proinsulin and acute insulin response independently predict Type 2 diabetes mellitus in men—report from 27 years of follow-up study
verfasst von
B. Zethelius, MD
L. Byberg
C. N. Hales
H. Lithell
C. Berne
Publikationsdatum
01.01.2003
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 1/2003
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-002-0995-2

Weitere Artikel der Ausgabe 1/2003

Diabetologia 1/2003 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

RAS-Blocker bei Hyperkaliämie möglichst nicht sofort absetzen

14.05.2024 Hyperkaliämie Nachrichten

Bei ausgeprägter Nierenfunktionsstörung steigen unter der Einnahme von Renin-Angiotensin-System(RAS)-Hemmstoffen nicht selten die Serumkaliumspiegel. Was in diesem Fall zu tun ist, erklärte Prof. Jürgen Floege beim diesjährigen Allgemeinmedizin-Update-Seminar.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.